Types

Research into acute myeloid leukemia has advanced in recent years, making it clear that acute myeloid leukemia is not a single disease but, rather, a disease that can take one of many forms.

Diagnosis

Several tests that examine cells in the blood and bone marrow are used to detect and diagnose acute myeloid leukemia.

Causes & symptoms

The most common signs and symptoms of acute myeloid leukemia include shortness of breath, bruising, fever, weakness, and infection. Usually, acute myeloid leukemia develops quickly and worsens unless it is treated.

What is acute myeloid leukemia?

Acute myeloid leukemia is a rare aggressive cancer of the blood and bone marrow and is the most common form of acute leukemia in adults.

Intensive chemotherapy, are there any other options?

During the EHA2021 Virtual Congress, Know AML spoke with Isolda Fernandez, FUNDALEU, Buenos Aires, AR. We asked, Are there any other options to intensive chemotherapy?

Addressing concerns around side effects in clinical trials

Know AML conducted a poll among patients with acute myeloid leukemia (AML), and their families and caregivers, revealing a concern regarding potential side effects that may be experienced during participation in a clinical trial.

Treating patients with FLT3-mutated AML: What you need to know

During the recent Know AML Ambassador Meeting, Professor Charles Craddock talked about treatments that are available for a type of acute myeloid leukemia (AML) with changes in the FLT3 gene, and discussed these with the other ambassadors.

How did long-term treatment with AML affect your lifestyle?

Know AML was pleased to speak with Ralph Hills, Know AML chair. We asked, How did long-term treatment affect your lifestyle?

Ralph’s story

Ralph Hills shares their experience with AML.

Dorcas' Story

Dorcas Hills shares their experience with AML.

Lee's story

Lee Mamwell shares their experience with AML.

Valerie's story

Valerie Fons shares their experience with AML.

Know AML spotlight: The KOMET-017 clinical trial

This educational resource is independently supported by Kura Oncology. All content was developed by SES in collaboration with an expert ambassador group. Funders were allowed no influence on the content of this resource.

The myeloMATCH trials screening test

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua

Website trust social graphics - Instagram, Facebook, LinkedIn - Editable

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Website trust social graphics - Twitter - Editable

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.